GenMont Biotech Incorporation - Laporan Laba Rugi (TTM)

GenMont Biotech Incorporation
TW ˙ TWSE
NT$ 20.15 ↑0.15 (0.75%)
2025-09-05
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi GenMont Biotech Incorporation menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 318 325 348 369 395 428 415 411 382 369 357 350 350 318 355 361 369 385 368 386
Change (%) 2.32 7.15 6.03 7.03 8.21 -2.99 -0.96 -7.12 -3.48 -3.07 -2.12 0.08 -9.12 11.57 1.76 2.07 4.57 -4.40 4.88
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 110 110 113 118 125 129 127 121 117 112 109 115 115 107 118 119 125 147 147 154
Change (%) -0.10 3.15 4.10 6.29 2.62 -0.94 -5.34 -2.84 -4.56 -2.45 5.18 0.19 -7.07 10.25 1.40 4.36 18.10 -0.23 4.89
% of Revenue 34.59 33.77 32.50 31.91 31.69 30.05 30.69 29.33 30.68 30.34 30.54 32.81 32.85 33.59 33.19 33.08 33.82 38.20 39.86 39.87
Gross Operating Profit 208 215 235 252 270 299 288 291 265 257 248 235 235 211 237 242 244 238 222 232
Change (%) 3.61 9.19 6.96 7.38 10.81 -3.88 0.98 -8.90 -3.01 -3.35 -5.32 0.02 -10.12 12.24 1.94 0.93 -2.34 -6.98 4.88
% of Revenue 65.41 66.23 67.50 68.09 68.31 69.95 69.31 70.67 69.32 69.66 69.46 67.19 67.15 66.41 66.81 66.92 66.18 61.80 60.14 60.13
SG&A 110 118 119 131 145 149 154 144 135 135 142 151 163 157 154 154 151 152 155 151
Change (%) 6.95 0.65 10.44 10.41 2.62 3.77 -6.43 -6.86 0.60 5.22 6.34 7.53 -3.37 -1.92 -0.04 -1.84 0.56 1.89 -2.98
% of Revenue 34.75 36.32 34.12 35.54 36.66 34.76 37.19 35.13 35.23 36.72 39.86 43.31 46.53 49.48 43.50 42.73 41.09 39.51 42.11 38.95
R&D 28 26 26 26 25 26 25 41 55 59 65 54 46 47 47 47 47 45 46 44
Change (%) -6.62 -2.56 1.12 -2.52 1.05 -2.81 65.87 33.14 8.45 8.79 -15.91 -15.71 2.29 0.68 0.38 -1.30 -3.15 2.21 -4.20
% of Revenue 8.86 8.09 7.35 7.01 6.39 5.96 5.98 10.01 14.35 16.12 18.09 15.54 13.09 14.74 13.30 13.12 12.68 11.75 12.56 11.47
OpEx 243 254 258 275 296 303 307 306 306 307 316 321 324 311 319 321 323 345 348 349
Change (%) 4.81 1.40 6.73 7.42 2.49 1.22 -0.13 0.10 0.03 3.11 1.39 0.96 -3.89 2.65 0.56 0.55 6.79 1.03 0.17
% of Revenue 76.32 78.18 73.98 74.46 74.73 70.78 73.85 74.47 80.26 83.19 88.50 91.67 92.48 97.80 89.99 88.92 87.59 89.46 94.54 90.29
Operating Income 75 71 91 94 100 125 109 105 75 62 41 29 26 7 36 40 46 41 20 38
Change (%) -5.70 27.75 4.06 5.90 25.15 -13.19 -3.31 -28.19 -17.77 -33.68 -29.09 -9.65 -73.46 408.43 12.61 14.27 -11.12 -50.46 86.34
% of Revenue 23.68 21.82 26.02 25.54 25.27 29.22 26.15 25.53 19.74 16.81 11.50 8.33 7.52 2.20 10.01 11.08 12.41 10.54 5.46 9.71
Interest Expense -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -2 -3 -4 -4 -4
Change (%) 2.15 -0.37 -0.00 -2.24 -2.42 -8.62 -9.71 -10.44 33.39 8.08 7.72 6.94 3.51 51.08 51.22 37.74 21.42 10.81 0.90
% of Revenue -0.25 -0.25 -0.23 -0.22 -0.20 -0.18 -0.17 -0.15 -0.15 -0.20 -0.23 -0.25 -0.27 -0.31 -0.41 -0.62 -0.83 -0.96 -1.12 -1.08
Net Income 49 61 83 82 77 113 106 103 87 57 42 33 49 33 59 71 53 57 39 16
Change (%) 23.34 35.62 -0.48 -6.80 47.71 -6.46 -2.87 -15.02 -34.77 -26.43 -21.07 47.64 -32.47 80.34 19.81 -25.45 7.73 -31.95 -60.08
% of Revenue 15.53 18.72 23.70 22.24 19.37 26.44 25.49 25.00 22.88 15.46 11.74 9.46 13.96 10.37 16.77 19.74 14.42 14.86 10.58 4.03

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista